packagePazopanib
pazopanib
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Pazopanib is a protein kinase inhibitor used to treat kidney cancer, especially renal cell carcinoma, and other tumours such as gastrointestinal stromal tumours and soft-tissue sarcomas. It is an approved anticancer medicine authorised in the European Union for renal cell carcinoma.
Summary written by glm-5.3-flash from Wikidata Q7157043 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | pazopanib |
| ATC codes: | L01EX03, L01XE11 |
| DrugBank: | DB06589 |
| PubChem CID: | 10113978 |
| ChEBI: | 71219 |
| Wikidata: | Q7157043 |
| formula: | C21H23N7O2S |
| molar mass: | 437.522 g/mol (PubChem CID 10113978) |
| logP: | 3.1 (Drugs.Common 25.09, not verified) |
Metabolites
NDesmethylImatinibNDMI | N-desmethyl-imatinib (NDMI) | 479.588 g/mol (pubchem) |
SU12662 | SU12662 | molar mass unknown |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |
Contents
| Name | Description |
|---|---|
| metabolite: N-desmethyl-imatinib (NDMI) | |
| metabolite: SU12662 |